Vibsane-type diterpenoids from Viburnum odoratissimum inhibit hepatocellular carcinoma cells via the PI3K/AKT pathway

• Published in: Phytomedicine (Stuttgart) 2023-01, Vol.108, p.154499-154499, Article 154499
• Main Authors: Xue, Xiao-Bian, Lv, Tian-Ming, Hou, Jiao-Yang, Li, Dan-Qi, Huang, Xiao-Xiao, Song, Shao-Jiang, Yao, Guo-Dong
• Format: Article
• Language: English
• Subjects: Hepatocellular carcinoma; PI3K/AKT pathway; Vibsane-type diterpenoids; Viburnum odoratissimum
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2022.154499

•Vibsane-type diterpenoids are the predominant constituents in EAVO by LC–MS/MS.•Transcriptomics reveals EAVO exerted anti-tumor activity by affecting the PI3K/AKT pathway.•EAVO can trigger apoptosis, induce mitochondrial damage and oxidative stress in HCC.•EAVO at all tested doses did not cause any mortality or remarkable side effects on Hep3B xenograft models. Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, with an elevated danger of metastasis and a short survival rate. Vibsane-type diterpenoids with novel structures possess marked antitumor activities against multiple cancer cells. However, the exact mechanism is poorly unclear. To assess the antitumor mechanism of vibsane-type diterpenoids derived from Viburnum odoratissimum (V. odoratissimum) against HCC cells in vitro and in vivo. The main constituents in the ethyl acetate extract of V. odoratissimum (EAVO) were identified by LC-MS/MS. The antiproliferative activity of EAVO in vitro was evaluated by MTT assays. Annexin V-FITC/PI, AO/EB, and Hoechst 33,258 staining were employed to detect apoptosis. JC-1 fluorescence dye was used to detect the mitochondrial membrane potential (MMP). The levels of intracellular ROS and mitochondrial superoxides were assessed by H2DCF-DA and MitoSox staining, respectively. The levels of oxidative stress were determined by ROS Green™ H2O2 probe, hydroxyphenyl fluorescein (HPF), and the C11 BODIPY 581/591 fluorescent probe. Transcriptomics was performed to investigate the antitumor mechanism of EAVO in HCC. The molecular mechanism by which EAVO suppressed HCC cells was verified by Western blot, RT-PCR, and HTRF® KinEASE™-STK S3 kits. The efficacy and safety of EAVO in vivo were evaluated using Hep3B xenograft models. Vibsane-type diterpenoids were the main constituents of EAVO by LC-MS/MS. EAVO suppressed proliferation, aggravated oxidative stress, and promoted apoptosis in HCC cells. Moreover, EAVO dramatically inhibited tumor growth in Hep3B xenograft models. Transcriptomics results indicated that EAVO inhibited HCC cell proliferation by regulating the PI3K/AKT pathway. Vibsanin B, vibsanol I, and vibsanin S isolated from EAVO was used to further verify the antitumor activity of vibsane-type diterpenoids subsequently. Interestingly, the kinase results showed that vibsanin B and vibsanol I exhibited vital AKT kinase inhibitory activities. Collectively, this study provided a comprehensive mechanism overview of vibsane-type diterpenoids against